National Research Center for Preventive Medicine Report issue

Government

Organization Overview

First Clinical Trial
2013
NCT04511520
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

National Research Center for Preventive Medicine

Active Ingredients

Drugs in Other Trials (3)

bisoprolol (zebeta) (1 trial)

normoxocin (1 trial)

trimetazidine (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 3